MERK.JK Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 07:02):

Stats
Šios dienos apimtis	6 500.00
Vidutinė apimtis	55 596.00
Rinkos kapitalizacija	1 800.96B
EPS	IDR87.11 ( 2023-09-30 )
Kita pelno data	( IDR0 ) 2024-05-29
Last Dividend	IDR0 ( N/A )
Next Dividend	IDR0 ( N/A )
P/E	10.10
ATR14	IDR11.56 (0.29%)

PT Merck Tbk Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

PT Merck Tbk Finansinės ataskaitos

Annual	2023
Pajamos:	IDR961.43B
Bruto pelnas:	IDR391.73B (40.74 %)
EPS:	IDR397.86

FY	2023
Pajamos:	IDR961.43B
Bruto pelnas:	IDR391.73B (40.74 %)
EPS:	IDR397.86

FY	2022
Pajamos:	IDR1 124.60B
Bruto pelnas:	IDR427.59B (38.02 %)
EPS:	IDR401.42

FY	2021
Pajamos:	IDR1 064.39B
Bruto pelnas:	IDR398.68B (37.46 %)
EPS:	IDR293.89

Financial Reports:

No articles found.

PT Merck Tbk

PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. It operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in discovering, developing, manufacturing, and marketing pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders comprising hyperthyroidism and hypothyroidism. In addition, it leases and manages properties. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. PT Merck Tbk is a subsidiary of Merck Holding GmbH.